Computational study of binding affinity to nuclear receptors for some cosmetic ingredients

Chemosphere

Volumn 135, Issue , 2015, Pages 325-334

  Plošnik, Alja ^a   Vračko, Marjan ^a   Mavri, Janez ^a  

^a NATIONAL INSTITUTE OF CHEMISTRY   (Slovenia)

Author keywords

Cosmetic ingredients; Endocrine disruption; In silico; Molecular docking; Nuclear receptors

Indexed keywords

BINDING ENERGY; COSMETICS; ENDOCRINE DISRUPTERS; MOLECULAR MODELING;

COSMETIC INGREDIENTS; ENDOCRINE DISRUPTION; IN-SILICO; MOLECULAR DOCKING; NUCLEAR RECEPTORS;

TRANSCRIPTION FACTORS;

CELL NUCLEUS RECEPTOR; COSMETIC; ENDOCRINE DISRUPTOR; GLUCOCORTICOID RECEPTOR; MINERALOCORTICOID RECEPTOR; PROGESTERONE RECEPTOR; CELL RECEPTOR;

CRYSTAL STRUCTURE; ENDOCRINE DISRUPTOR; PROTEIN; TOXIC SUBSTANCE;

ARTICLE; BINDING AFFINITY; BINDING SITE; COMPUTER MODEL; CRYSTAL STRUCTURE; HUMAN; MOLECULAR DOCKING; MOLECULAR WEIGHT; PREDICTION; PROTEIN CONFORMATION; RECEPTOR BINDING; CHEMICAL MODEL; CHEMISTRY; COMPUTER SIMULATION;

COMPUTER SIMULATION; COSMETICS; ENDOCRINE DISRUPTORS; HUMANS; MODELS, CHEMICAL; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 84930455276     PISSN: 00456535     EISSN: 18791298     Source Type: Journal    
DOI: 10.1016/j.chemosphere.2015.04.075     Document Type: Article

References (29)

1. Anzali S., Berthold M.R., Fioravanzo E., Neagu D., Péry A., Worth A.P., Yang C., Cronin M.T.D., Richarz A. Development of computational models for the risk assessment of cosmetic ingredients. IFSCC Mag. 2012, 15:249-255.
2. Baell B.J., Holloway G.A. New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J. Med. Chem. 2010, 53:2719-2740.
3. Chen J., Chang Ahn K., Gee N.A., Ahmed M.I., Duleba A.J., Zhao L., Gee S.J., Hammock B.D., Lasley B.L. Triclocarban enhances testosterone action: a new type of endocrine disruptor?. Endocrinology 2008, 149:1173-1179.
4. Diamanti-Kandarakis E., Bourguignon J., Giudice L.C., Hauser r., Prins G.S., Soto A.M., Zoeller R.T., Gore A.C. Endocrine-disrupting chemicals: an endocrine society scientific statement. Endocr. Rev. 2009, 30(4):293-342.
5. Endocrine Disruptome (accessed 10.07.14). http://endocrinedisruptome.ki.si/.
6. European Workshop on the impact of endocrine disruptors on human health and wildlife (workshop report, 1996) (accessed 30.07.14). http://ec.europa.eu/environment/chemicals/endocrine/documents/reports_conclusions_en.htm.
7. Extension Toxicology Network. Pesticide Information Profile: Resmethrin. Corvallis: Oregon State University, 1996.
8. Go V., Garey J., Wolff M.S., Pogo G.T. Estrogenic potential of certain pyrethroid compounds in the MCF-7 human breast carcinoma cell line. Environ. Health Perspect. 1999, 107:173-177.
9. Hofkamp L., Bradley S., Tresguerres J., Lichtensteiger W., Schlumpf M., Timms B. Region-specific growth effects in the developing rat prostate following fetal exposure to estrogenic ultraviolet filters. Environ. Health Perspect. 2008, 116:867-872.
10. *. Pure Appl. Chem. 2003, 75:1881-1893.
11. Inventory CosIng Database (accessed 07.02.14). http://ec.europa.eu/consumers/cosmetics/cosing/.
12. Jimenez-Diaz I., Molina-Molina M.J., Zafra-Gomez A., Ballesteros O., Navalon A., Real M., Saenz J.M., Fernandez M.F., Olea N. Simultaneous determination of the UV-filters benzyl salicylate, phenyl salicylate, octyl salicylate, homosalate, 3-(4-methylbenzyllidene) camphor and 3-benzylidene camphor in human placental tissue by LC-MS/MS. vitro endocrine activity. J. Chromatogr. 2013, 936:80-87.
13. Lakshmi B.A., DeCaprio D. Cheminformatics approaches to analyze diversity in compound screening libraries. Curr. Opin. Chem. Biol. 2010, 14:325-330.
14. Marques-Pinto A., Carvalho D. Human infertility: are endocrine disruptors to blame?. Endocr. Connections 2013, 2:R15-R29.
15. Muster W., Breidenbach A., Fischer H., Kirchner S., Muller L., Pahler A. Computational toxicology in drug development. Drug Discovery Today 2008, 13:303-310.
16. Novič M., Vračko M. QSAR models for reproductive toxicity and endocrine disruption activity. Molecules 2010, 15:1987-1999.
17. Kolšek K., Mavri J., Sollner Dolenc M., Gobec S., Turk S. Endocrine disruptome-an open source prediction tool for assessing endocrine disruption potential through nuclear receptor binding. J. Chem. Inf. Model. 2013, 10.1021/ci400649p.
18. Lo Piparo, Worth, A., 2010. Review of QSAR Models and Softwae Tools for predicting Developmental and Reproductive Toxicity. JRC Scientific and Technical Reports, pp. 1-24.
19. PubChem system (accessed 11.02.14). https://pubchem.ncbi.nlm.nih.gov/.
20. REACH legislation-Registration, Evaluation, Authorisation and Restriction of Chemicals. (accessed 28.08.14). http://ec.europa.eu/enterprise/sectors/chemicals/reach/index_en.htm.
21. REGULATION (EC) No 1223/2009 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL, 2009. (accessed 05.03.15). http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2009:342:0059:0209:en:PDF.
22. Rüegg J., Penttinen-Damdimopoulou P., Mäkelä S., Pongratz I., Gustafsson J. Receptors mediating toxicity and their involvement in endocrine disruption, Molecular, Clinical and Environmental Toxicology. Mol. Toxicol. 2009, 1:289-323.
23. Schlumpf M., Jarry H., Wuttke W., Maa R., Lichtensteiger W. Estrogenic activity and estrogen receptor binding of the UV filter 3-benzylidene camphor Comparison with 4-methylbenzylidene camphor. Toxicology 2004, 199:109-120.
24. Schlumpf M., Schmid S., Durrer S., Consciencea M., Maerkel K., Henseler M., Gruetter M., Herzog I., Reolon S., Ceccatelli R., Faass O., Stutz E., Jarry H., Wuttke W., Lichtensteigera W. Endocrine activity and developmental toxicity of cosmetic UV filters-an update. Toxicology 2004, 205:113-122.
25. Tollefsen K.E., Scholz S., Cronin M.T., Edwards S.W., Knecht J., Crofton K., Garcia-Reyero N., Hartung T., Worth A., Patlewicz G. Applying Adverse Outcome Pathways (AOPs) to support Integrated Approaches to Testing and Assessment (IATA). Regul. Toxicol. Pharmacol. 2014, 70:629-640.
26. Vedani A., Smiesko M., Spreafico M., Peristera O., Dobler M. VirtualToxLab™ - in silico prediction of the toxic (endocrine-disrupting) Potential of Drugs, Chemicals and Natural Products. Two Years and 2000 Compounds of Experience: a progress report. Altex 2009, 26:167-176.
27. Vedani A., Dobler M., Smiesko M. VirtualToxLab - a platform for estimating the toxic potential of drugs, chemicals and natural products. Toxicol. Appl. Pharmacol. 2012, 261:142-153.
28. Vinggaard A.M., Niemelä J., WedebyeE B., Egeskov Jensen G. Screening of 397 chemicals and development of a quantitative structure-activity relationship model for androgen receptor antagonism. Chem. Res. Toxicol. 2008, 21:813-823.
29. Vuorinen A., Odermatt A., Schuster D. In silico methods in the discovery of endocrine disrupting chemicals. J. Steroid Biochem. Mol. Biol. 2013, 137:18-26.